These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12175677)
21. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Ito H; Hiroe M; Hirata Y; Tsujino M; Adachi S; Shichiri M; Koike A; Nogami A; Marumo F Circulation; 1993 May; 87(5):1715-21. PubMed ID: 7683979 [TBL] [Abstract][Full Text] [Related]
22. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Lee SD; Chu CH; Huang EJ; Lu MC; Liu JY; Liu CJ; Hsu HH; Lin JA; Kuo WW; Huang CY Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E306-14. PubMed ID: 16825605 [TBL] [Abstract][Full Text] [Related]
23. An interaction between inositol hexakisphosphate (IP6) and insulin-like growth factor II receptor binding sites in the rat brain. Kar S; Quirion R; Parent A Neuroreport; 1994 Jan; 5(5):625-8. PubMed ID: 8025258 [TBL] [Abstract][Full Text] [Related]
24. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705 [TBL] [Abstract][Full Text] [Related]
25. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway. Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089 [TBL] [Abstract][Full Text] [Related]
26. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats. Jiang H; Zhang C; He W Med Sci Monit; 2018 Sep; 24():6322-6330. PubMed ID: 30199522 [TBL] [Abstract][Full Text] [Related]
27. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503 [TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Donath MY; Zapf J; Eppenberger-Eberhardt M; Froesch ER; Eppenberger HM Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1686-90. PubMed ID: 8127866 [TBL] [Abstract][Full Text] [Related]
29. Alterations in insulin-like growth factor-I signaling in cardiomyocytes from chronic alcohol-exposed rats. Pecherskaya A; Rubin E; Solem M Alcohol Clin Exp Res; 2002 Jul; 26(7):995-1002. PubMed ID: 12170109 [TBL] [Abstract][Full Text] [Related]
30. Alternate signaling pathways selectively regulate binding of insulin-like growth factor I and II on fetal rat bone cells. McCarthy TL; Ji C; Casinghino S; Centrella M J Cell Biochem; 1998 Mar; 68(4):446-56. PubMed ID: 9493908 [TBL] [Abstract][Full Text] [Related]
31. Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60. Lai HC; Liu TJ; Ting CT; Yang JY; Huang L; Wallace D; Kaiser P; Wang PH Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E292-7. PubMed ID: 16985260 [TBL] [Abstract][Full Text] [Related]
32. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207 [TBL] [Abstract][Full Text] [Related]
33. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. McDevitt TC; Laflamme MA; Murry CE J Mol Cell Cardiol; 2005 Dec; 39(6):865-73. PubMed ID: 16242146 [TBL] [Abstract][Full Text] [Related]
34. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro. Han HJ; Kang CW; Park SH Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497 [TBL] [Abstract][Full Text] [Related]
35. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy. Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324 [TBL] [Abstract][Full Text] [Related]
36. HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor. Bareja A; Hodgkinson CP; Payne AJ; Pratt RE; Dzau VJ Biochem J; 2017 Feb; 474(5):771-780. PubMed ID: 28096202 [TBL] [Abstract][Full Text] [Related]
37. Targeting insulin-like growth factor signaling: rational combination strategies. Olmos D; Basu B; de Bono JS Mol Cancer Ther; 2010 Sep; 9(9):2447-9. PubMed ID: 20807783 [No Abstract] [Full Text] [Related]
38. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy. Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663 [TBL] [Abstract][Full Text] [Related]
39. Prolactin protects cardiomyocytes against intermittent hypoxia-induced cell damage by the modulation of signaling pathways related to cardiac hypertrophy and proliferation. Hsieh DJ; Huang CY; Pai P; Wang SG; Tsai YL; Li CN; Kuo WW; Huang CY Int J Cardiol; 2015 Feb; 181():255-66. PubMed ID: 25531577 [TBL] [Abstract][Full Text] [Related]
40. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72. Ham YM; Mahoney SJ Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]